C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Philogen Announces New Collaboration With Janssen To Discover Small Molecule Therapeutics

Wednesday, November 24, 2021

Philogen SpA a clinicalstage biotechnology company focused on antibody and small moleculebased targeted therapeutics today announces that its whollyowned Swiss subsidiary Philochem AG has entered into a new collaboration and option agreement with Jan...

Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

Wednesday, November 24, 2021

Supernus Pharmaceuticals Inc today announced that it has successfully completed its previously announced acquisition of Adamas Pharmaceuticals Inc Adamas fits squarely within our corporate development strategy adding a latestage commercial product wi...

Eppendorf donates 20,000 euros to the EMBL to promote women working in science

Tuesday, November 23, 2021

Eppendorf SE donated euros to the European Molecular Biology Laboratory EMBL during an online presentation ceremony The funds are for the EMBL project Advancement of Women in Science which enables women scientists to begin managerial careers in scie...

Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headache in Chronic Migraineurs

Tuesday, November 23, 2021

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced the US Food and Drug Administration FDA has cleared the Investigational New Drug IND Application to support the initiation of a Phase study of TNX intranasa...

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory

Tuesday, November 23, 2021

Takeda Pharmaceutical Company Limited today announced that the US Food and Drug Administration FDA has approved LIVTENCITY maribavir for the treatment of adults and pediatric patients years of age or older and weighing at least kg with posttranspla...

BioCorRx Acquires Intellectual Property for Drug Delivery

Monday, November 22, 2021

BioCorRx Inc a developer and provider of innovative treatment programs for substance abuse and related disorders today announced that the Company has acquired a patent application from Calista Therapeutics The current application was filed with the...

Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss

Monday, November 22, 2021

Decibel Therapeutics a clinicalstage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance today announced that Regeneron has extended the research term of its collaboration...

Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders

Monday, November 22, 2021

Neurocrine Biosciences Inc and Sosei Group Corporation announce the signing of a strategic collaboration and licensing agreement to develop novel muscarinic receptor agonists which Neurocrine Biosciences intends to study in the treatment for schizoph...

BiVictriX and Abzena Collaborate to Manufacture Antibody-Drug Conjugates

Friday, November 19, 2021

BiVictriX Therapeutics plc an emerging biotechnology company applying a novelapproach to develop next generation cancer therapies using insights derived from frontline clinical experienceis pleased to announce a collaboration to manufacture BiVictriX...

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery

Thursday, November 18, 2021

Merck known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has approved KEYTRUDA Mercks antiPD therapy for the adjuvant treatment of patients with renal cell carcinoma RCC at intermediatehigh...

Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership to Enable Broader Collaboration in China

Thursday, November 18, 2021

Cytovia Therapeutics Inc a biopharmaceutical company developing allogeneic offtheshelf geneedited iNK NK cells derived from iPSC and CAR Chimeric Antigen Receptor Natural Killer NK cells derived from induced pluripotent stem cells iPSCs and FlexNK ce...

Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy

Thursday, November 18, 2021

Verrica Pharmaceuticals Inc a dermatology therapeutics company developing medications for skin diseases requiring medical interventions today announced that the US Food and Drug Administration FDA has accepted the Companys Investigational New Drug Ap...

Turkish Cargo participated in ‘’Logitrans – 2021’’ fair

Tuesday, November 16, 2021

The global air cargo brand Turkish Cargo participated this year in Logitrans Turkeys most extensive international transportation and logistics fair for the th time Having a m wide stand area in the fair organized in CNR EXPO Istanbul Fair Center on...

Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

Tuesday, November 16, 2021

Emmes a global fullservice Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation today announced a partnership with MedGenome aimed at accelerating breakthrough treatments powered by...

Merck Launches ColorWheel® Flow Cytometry Antibodies and Dyes to Provide Flexibility in Flow Cytometry Workflows

Tuesday, November 16, 2021

Merck announced the launch of its new ColorWheel flow cytometry portfolio utilizing a proprietary technology optimized for flow cytometry that allows users to independently select antibodies and dyes for assembly in any desired combination The output...

Terumo Blood and Cell Technologies and Immunicom establish agreement to launch breakthrough cancer immunotherapy treatment in Europe

Tuesday, November 16, 2021

Terumo Blood and Cell Technologies a medical technology company specializing in a portfolio of products software and services for blood component collection therapeutic apheresis and cellular technologies and Immunicom Inc a clinicalstage biotech pio...

INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

Tuesday, November 16, 2021

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases cancer and HPVassociated diseases today announced that several volunteers have been dosed with its DNAb...

Rakovina Therapeutics Partners with St. Baldrick’s Foundation to Research and Develop New Treatments for Childhood Bone Cancer

Tuesday, November 16, 2021

Rakovina Therapeutics Inc a biopharmaceutical company committed to advancing new cancer therapies based on novel DNAdamage response technologies today announced that the Company has been selected to join a three year US CDN research program funded by...

Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT

Tuesday, November 16, 2021

Hoth Therapeutics Inc a patientfocused biopharmaceutical company today announced that it has signed a Sponsored Research Agreement with North Carolina State University NC State to support the continued research and development of HTKIT a novel therap...

New hope for bowel cancer patients as fresh partnership between Carina Biotech and CellVec enables advancement of clinical trials

Monday, November 15, 2021

Singaporebased viral vector CDMO CellVec announces today that it has been selected as the manufacturer of choice for Australian cell therapy immunooncology company Carina Biotech undertaking the production of GMPcompliant lentivirus constructs...

Turkish Cargo awarded with ‘Air Cargo Excellence’ by WOF EXPO

Monday, November 15, 2021

Possessing the worlds strongest cargo flight network Turkish Cargo has received the Air Cargo Excellence award in different categories in Slovakia Bratislava The first logistics exhibition in Central and Eastern Europe run by WOF EXPO at Awards Gala...

Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine

Monday, November 15, 2021

Astellas Pharma Inc and Pantherna Therapeutics GmbH today announced that the companies have entered into a technology evaluation agreement for the research of mRNAbased regenerative medicine Pantherna has a technology platform consisting of unique mR...

Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED)

Monday, November 15, 2021

Kala Pharmaceuticals Inc a commercialstage biopharmaceutical company focused on the discovery development and commercialization of innovative therapies for diseases of the eye today announced that it has acquired Combangio Inc a private clinicalstage...

Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) for Patients

Monday, November 15, 2021

Rhythm Pharmaceuticals Inc a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity today announced that the US Food and Drug Administration FDA has accepted for filing the co...

Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®

Monday, November 15, 2021

Eton Pharmaceuticals Inc today announced that it has entered into a multiyear agreement with Tolmar Pharmaceuticals Inc to copromote ALKINDI SPRINKLE Eton will leverage Tolmars person sales force and their existing relationships in the pediatric endo...

SOT101 Shows Clinical Benefit in Patients with Advanced Solid Tumors

Saturday, November 13, 2021

SOTIO Biotech a clinical stage immunooncology company owned by PPF Group today announced new data from the ongoing Phase b AURELIO study of SOT an IL superagonist as a monotherapy and in combination with pembrolizumab in patients with advancedmetasta...

ZIPLINE, PFIZER AND BIONTECH COLLABORATION PAVES THE WAY FOR AUTOMATED, ON-DEMAND DELIVERY OF FIRST MRNA COVID-19 VACCINES IN GHANA

Friday, November 12, 2021

Zipline the global leader in instant logistics Pfizer Inc and BioNTech SE today announced that Zipline has successfully completed the first longrange drone delivery of both authorized mRNA COVID vaccines requiring ultracoldchain in Ghana The collabor...

ONCORUS ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH GAETA THERAPEUTICS LTD. FOR USE OF LOCALLY DELIVERED INTERLEUKIN-12

Friday, November 12, 2021

Oncorus Inc a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients today announced that it has signed an exclusive licensing agreement with Gaeta Therapeutics Ltd related to the use of locally delivere...

ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma

Friday, November 12, 2021

ANI Pharmaceuticals Inc today announced that the US Federal Trade Commission has accepted the proposed consent order in connection with ANIs definitive agreement to acquire Novitium Pharma The divestitures required by the FTC of development rights to...

Lonza to Acquire Exosomics Service Unit to Expand Exosomes Service Offering

Friday, November 12, 2021

Lonza a global manufacturing partner to the pharmaceutical biotech and nutrition industries announced today the acquisition of the service unit from Exosomics a leading extracellular vesicles biotech company The agreement includes Exosomics service t...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations Catalent  Asia-Pacific Clinical Supply Solutions SGS - Health Science Horizon - CHOSOURCE advances biotherapeutic production MasterControl - The Never-Normal Future of Manufacturing Medical Fair Thailand 2022 Meco - 90 years